2025 Annual Meeting | S4 - Movement Disorders: Basic Science
Program Materials Program Evaluations
| Bernard Brais, MD | Dr. Brais has nothing to disclose. |
| Janis M. Miyasaki, MD, MEd, FAAN | Dr. Miyasaki has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for 好色先生. Dr. Miyasaki has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oxford University Press. The institution of Dr. Miyasaki has received research support from PCORI. The institution of Dr. Miyasaki has received research support from Brain Canada. The institution of Dr. Miyasaki has received research support from Canadian Consortium on Neurodegeneration in Aging. The institution of Dr. Miyasaki has received research support from University Hospital Foundation. The institution of Dr. Miyasaki has received research support from Social Science and Health Research Council. |
| Ergun Y. Uc, MD | An immediate family member of Dr. Uc has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Board of Pediatrics. The institution of Dr. Uc has received research support from Department of Veterans Affairs. The institution of Dr. Uc has received research support from Department of Defense. The institution of an immediate family member of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from Parkinson's Foundation. The institution of Dr. Uc has received research support from NIH. |
| Alexis Brice, MD | Dr. Brice has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for ICM. |
| David K. Simon, MD, PhD | Dr. Simon has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Bial Biotech. An immediate family member of Dr. Simon has stock in Biogen. The institution of Dr. Simon has received research support from Weston Brain Institute. The institution of Dr. Simon has received research support from NIH. The institution of Dr. Simon has received research support from Neuraly. Dr. Simon has received personal compensation in the range of $5,000-$9,999 for serving as a Steering Committee Member: SPARK clinical study with Biogen. Dr. Simon has received personal compensation in the range of $500-$4,999 for serving as a Steering Committee Member: NILO-PD clinical study with Michael J Fox Foundation. |
| Cyrus P. Zabetian, MD | The institution of Dr. Zabetian has received research support from American Parkinson Disease Association. The institution of Dr. Zabetian has received research support from Department of Veterans Affairs. The institution of Dr. Zabetian has received research support from NIH. Dr. Zabetian has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities. |
| Alexandra Durr, MD | The institution of Dr. Durr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Durr has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. The institution of Dr. Durr has received research support from NIH. The institution of Dr. Durr has received research support from BIOGEN. The institution of Dr. Durr has received research support from MINORYX. The institution of Dr. Durr has received research support from TRIPLETS THERAPEUTICS. The institution of Dr. Durr has received research support from Servier. The institution of Dr. Durr has received research support from ANR. The institution of Dr. Durr has received research support from PTC. |
| Anumantha G. Kanthasamy | Anumantha G. Kanthasamy has received personal compensation for serving as an employee of Probiome Therapeutics. Anumantha G. Kanthasamy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Institute of Health. Anumantha G. Kanthasamy has stock in Google, meta and Amazon. The institution of Anumantha G. Kanthasamy has received research support from NIH , DoD and MJFF. Anumantha G. Kanthasamy has received intellectual property interests from a discovery or technology relating to health care. Anumantha G. Kanthasamy has received personal compensation in the range of $500-$4,999 for serving as a Consultant with NIH. |
| Lindsey L. Lair, MD, FAAN | Dr. Lair has received personal compensation for serving as an employee of Biohaven. An immediate family member of Dr. Lair has received personal compensation for serving as an employee of PPD/Thermo Fisher Scientific. Dr. Lair has stock in Biohaven. An immediate family member of Dr. Lair has stock in PPD/Thermo Fisher Scientific. Dr. Lair has a non-compensated relationship as a Board Member with NY State Neurological Society that is relevant to AAN interests or activities. |
| Irfan Qureshi, MD | Dr. Qureshi has received personal compensation for serving as an employee of Biohaven. Dr. Qureshi has stock in Biohaven Pharmaceuticals. |
| Stephan Zuchner, MD, FAAN | Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care. |
| Alice Chen-Plotkin, MD | Dr. Chen-Plotkin has received intellectual property interests from a discovery or technology relating to health care. |
| Alexander Shtilbans, MD, PhD, FAAN | Dr. Shtilbans has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Shtilbans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal Pharmaceuticals. The institution of Dr. Shtilbans has received research support from NIH. The institution of Dr. Shtilbans has received research support from Praxis Precision Medicines. |
| Virginia Lee, PhD | Virginia Lee, PhD has nothing to disclose. |
| Thomas F. Tropea, DO | Dr. Tropea has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. The institution of Dr. Tropea has received research support from NINDS. The institution of Dr. Tropea has received research support from Parkinson Foundation. The institution of Dr. Tropea has received research support from Michael J Fox Foundation. |
| Marie Y. Davis, MD, PhD | Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Davis has received research support from NIH NINDS. The institution of Dr. Davis has received research support from University of Washington Institute for Stem Cell and Regenerative Medicine. The institution of Dr. Davis has received research support from VA BLRD. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a study section grant reviewer with NIH. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with Parkinson's Foundation. |
| Hwai Y. Ooi, MD | Dr. Ooi has nothing to disclose. |
| Jill S. Napierala, PhD | Dr. Napierala has nothing to disclose. |
| David Pellerin, MD | Dr. Pellerin has nothing to disclose. |
| George Kannarkat | Dr. Kannarkat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Kannarkat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for MDCalc. |
| Michele Persico, MD | Dr. Persico has nothing to disclose. |
| Arnav Khera | Mr. Khera has nothing to disclose. |
| Oswaldo Lorenzo Betancor, PhD | The institution of Dr. Lorenzo Betancor has received research support from Department of Veterans Affairs. The institution of Dr. Lorenzo Betancor has received research support from Michael J. Fox Foundation. |
| Tracy-Shi Zhang Fang, PhD | Dr. Fang has nothing to disclose. |
| Bavani Shankar | Ms. Shankar has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Transcenta Therapeutics. |
| Jeremy R. Weiss | Mr. Weiss has nothing to disclose. |
| Caroline Kwon | Ms. Kwon has nothing to disclose. |
| Vlad Coric | No disclosure on file |
| Nick Kozauer | Dr. Kozauer has received personal compensation for serving as an employee of Biohaven. Dr. Kozauer has stock in Biohaven. |
| Bruce D. Car | Dr. Car has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Car has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PathAI. Dr. Car has stock in BHVN. Dr. Car has received intellectual property interests from a discovery or technology relating to health care. |
| Jeffrey Dawson | Jeffrey Dawson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for iotaMotion. Jeffrey Dawson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Congress of Neurological Surgeons. The institution of Jeffrey Dawson has received research support from Department of Veterans Affairs. The institution of Jeffrey Dawson has received research support from NIH. |
| Marie-Josee Dicaire | Marie-Josee Dicaire has nothing to disclose. |
| Dora Yearout | The institution of Dora Yearout has received research support from Veterans Affairs, NIH, and MJFF reserach grants. |
| Leo Pallanck | No disclosure on file |
| Robert Skrinak | No disclosure on file |
| Selina Yu | Selina Yu has nothing to disclose. |
| Matt Danzi | Matt Danzi has nothing to disclose. |
| Simona Eleuteri | Simona Eleuteri has received intellectual property interests from a discovery or technology relating to health care. |
| Sarah Fish | Sarah Fish has nothing to disclose. |
| Christina Weber | Christina Weber has nothing to disclose. |
| Kelvin Luk | The institution of Kelvin Luk has received research support from National Institutes of Health. The institution of Kelvin Luk has received research support from Michael J. Fox Foundation. The institution of Kelvin Luk has received research support from Teva Pharmaceuticals. |
| Anna Park | Miss Park has nothing to disclose. |
| Susana Boluda | Susana Boluda has nothing to disclose. |
| Rebecca Zack | Rebecca Zack has nothing to disclose. |
| Danielle D. Seilhean, MD, PhD | Prof. SEILHEAN has nothing to disclose. |
| Jean-Loup Méreaux, MD | The institution of Dr. Méreaux has received research support from Fondation pour la Recherche Médicale FRM. The institution of Dr. Méreaux has received research support from Biogen. |
| David Genís Batlle, MD | Dr. GENÍS BATLLE has nothing to disclose. |
| Claire-Sophie Davoine, Engineer | Mrs. DAVOINE has nothing to disclose. |
| Mathilde Renaud, MD, PhD | Prof. Renaud has nothing to disclose. |
| Brandon Gerhart | Mr. gerhart has nothing to disclose. |
| Laura Molina-Porcel, MD, PhD | Dr. Molina-Porcel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. |
| Guinevere Spurdens | Miss Spurdens has nothing to disclose. |
| Cheng-Tsung Hsiao, MD, PhD | Dr. Hsiao has nothing to disclose. |
| Patrick Aro, MS | Mr. Aro has nothing to disclose. |
| Min Shi, PhD | The institution of Dr. Shi has received research support from NIH. The institution of Dr. Shi has received research support from DoD. |
| Joshua Weiss, PharmD | Mr. Weiss has nothing to disclose. |
| Chung-Jiuan Jeng, PhD | Prof. Jeng has nothing to disclose. |
| Ssu-Ju Fu, PhD | Dr. Fu has nothing to disclose. |
| Elise Esneault, PhD | Dr. Esneault has received personal compensation for serving as an employee of Porsolt. |
| Florian Simon, MSc | Mr. SIMON has nothing to disclose. |
| Dror M. Rom | Dr. Rom has nothing to disclose. |
| Marek Napierala, PhD | The institution of Dr. Napierala has received research support from NIH and FARA. |
| Wolfgang Reintsch, PhD | Mr. Reintsch has nothing to disclose. |
| Chih-Yung Tang, PhD | Prof. Tang has nothing to disclose. |
| Vellareddy Anantharam, PhD | Dr. Anantharam has nothing to disclose. |
| Valerio E. Piscopo, PhD | Dr. Piscopo has nothing to disclose. |
| Michelle E. Lenz, RN | Ms. Lenz has received personal compensation for serving as an employee of VA Research Foundation. |
| Chris Liang, PhD | Dr. Liang has received personal compensation for serving as an employee of Highlightll. Dr. Liang has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Highlightll. Dr. Liang has stock in Highlightll. Dr. Liang has received intellectual property interests from a discovery or technology relating to health care. |
| Jillian Hammond | Ms. Hammond has nothing to disclose. |
| Wei Tang, PhD | Dr. Tang has nothing to disclose. |
| Ella Chiu | Miss Chiu has nothing to disclose. |
| Andrea Krahn | Ms. Krahn has nothing to disclose. |
| Caroline A. Lewis | Ms. Lewis has nothing to disclose. |
| Thomas M. Durcan, PhD | Dr. Durcan has nothing to disclose. |
| Dmitry Ter-Ovanesyan, PhD | Dr. Ter-Ovanesyan has received intellectual property interests from a discovery or technology relating to health care. |
| Drew Quiriconi | Mr. Quiriconi has nothing to disclose. |
| Joe Mazzulli, PhD | Dr. Mazzulli has stock in Lysosomal Therapeutics Inc. |
| Céline BONNET, MD | Prof. BONNET has nothing to disclose. |
| Ira Deveson, PhD | Dr. Deveson has nothing to disclose. |
| David R. Walt, PhD | No disclosure on file |
| Travis Unger | Mr. Unger has nothing to disclose. |
| Tal Gilboa | No disclosure on file |